Invokana Ketoacidosis Risk also Seen in Type 1 Diabetics
As concern over risks associated with the type 2 diabetes drug Invokana continues to rise, a new study has shown the same dangers seen with the drug in type 2 diabetes patients may also be present in those with type 1 diabetes. Researchers have found that off-label use of this... Read more »